Envista Holdings Corporation acquired Matricel GmbH for approximately $43.6 million, a transaction completed in January 2020, structured as all cash.
Matricel GmbH operates in Specialty Products & Technologies, is based in Germany. Envista acquired all of the shares of Matricel GmbH, a German developer of biomaterials used in dental applications, for roughly $43.6 million in cash. The deal was disclosed as a subsequent event in Envista's FY2019 Form 10-K and closed on January 21, 2020. Matricel became part of the Specialty Products & Technologies segment, and the purchase price was expected to consist primarily of intangible assets.
Deepen Envista's specialty and implant-adjacent portfolio with proprietary dental biomaterials.
Adds proprietary dental biomaterials expertise to the implant/specialty portfolio. Specialty Products & Technologies segment
On January 21, 2020, we acquired all of the shares of Matricel GmbH (Matricel) for cash consideration of approximately $43.6 million. Matricel, a German company, is a provider of biomaterials used in dental applications and is part of our Specialty Products and Technologies segment.Envista Holdings Corporation FY2019 Form 10-K, Note 22 Acquisitions (subsequent event)
Advisory firms were not disclosed for this transaction.